BrightPath Biotherapeutics
Tokyo
About BrightPath Biotherapeutics
BrightPath Biotherapeutics is a stage biopharmaceutical company focused on developing novel cancer immunotherapies. The company develops products based on peptide vaccine technology that stimulates a potent immune response to tumor-associated antigens.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $11.5M
- Funding stage: IPO
- Last round: Series Unknown (Aug 2014)
- Ticker: tyo:4594
- Website: brightpathbio.com
- Phone: +81 942 38 6550
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/brightpath-biotherapeutics-2990004 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.